Experience with invasive Candida infections

Postgraduate Medical Journal

Volumn 75, Issue 881, 1999, Pages 151-153

  Girishkumar, Hanasoge ^a   Yousuf, Arshad M ^a   Chivate, Jayant ^a   Geisler, Edward ^a   King, Saundra ^a  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

Candida; Invasive infection; Risk factors

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDIASIS; CENTRAL VENOUS CATHETER; CHILD; CHILL; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; FEVER; FUNGEMIA; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KIDNEY FAILURE; LENGTH OF STAY; LEUKOPENIA; LIVER FAILURE; MALE; MORTALITY; MUSCLE WEAKNESS; NEWBORN; RESPIRATORY FAILURE; SYMPTOM;

EID: 0033044946     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.75.881.151     Document Type: Article

References (19)

1. Rinaldi MG. Biology and pathogenicity of Candidal species. In: Bodey GP, ed. Candidiasis: pathogenesis, diagnosis and treatment, 2nd edn. New York: Raven Press; 1993; pp 1-20.
2. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1989;91:86-9.
3. Dean DA, Burchard KW. Fungal infection in surgical patients. Am J Surg 1996;71:374-82.
4. Beck-Sague CM, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993;167:1247-51.
5. Wey SB, Mon M, Pfaller MA. Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intern Med 1989;149:2349-53.
6. Odds FC. Candida infections: an overview. Crit Rev Microbiol 1987;15:1-5.
7. Wade JC. Epidemiology of Candida infections. In: Bodey GP, ed. Candidiasis: pathogenesis, diagnosis and treatment, 2nd edn. New York: Raven Press; 1993; pp 85-107.
8. Nolia-Salas J, Sitges-Serra A, Leon-Gill C. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study group of fungal infection in the ICU. Intens Care Med 1997; 23:23-30.
9. Walsh TJ, Pizzo PA. Laboratory diagnosis of candidiasis. In:Bodey GP, ed. Candidiasis: pathogenesis, diagnosis and treatment, 2nd edn. New York: Raven Press; 1993; pp109-35.
10. Voss A, Le Noble JL, Verduyn-Lunel FM, Meis JF. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997;25:8-11.
11. Gonzalez CE, Venzon D, Lee S, Mueller BU, Pizzo PA, Walsh TJ. Risk factors for fungemia in children infected with human immunodeficiency virus- a case control study. Clin Infect Dis 1996;23:515-21.
12. Krcmery V, Oravcova E, Spanik S, Mrazova-Srudena M, Trupl J, Kunova A. Nosocomial breakthrough fungemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of etiology, risk factors and outcome. J Antimicrob Chem 1998;41:373-80.
13. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in fibrile granulocytopenic patients. Am J Med 1989;86:668-72.
14. Walsh TJ, Lee JW. Prevention of invasive fungal infections in patients with neoplastic diseases. Clin Infect Dis 1993; 17(S2):S468-S480.
15. Eubanks PJ, Virgilio CD, Klein S, Bongard F. Candida sepsis in surgical patients. Am J Surg 1993;166:617-20.
16. Karabinis A, Hill C, Leclercq B, et al. Risk factors for candidemia in cancer patients: a case control study. J Clin Microbiol 1988;26:429-32.
17. Meunier F. Candidiasis. Eur J Clin Microbiol Infect Dis 1989; 8:438-47.
18. Al Soub H, Estinoso W. Hospital acquired candidemia: experience from a developing country. J Hosp Infect 1997;35:141-7
19. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;25:1274-7.